ニュースImclone is developing monoclonal antibodies for cancer treatment.Shah began his career as a clinician, but soon moved over into the biotech sector to work at ImClone, a subsidiary of Eli Lilly, developing monoclonal antibodies for cancer treatment.
ニュースEli Lilly acquired Imclone for $6.5B on Jan 1st '08.Founded by Waksal in 1984, ImClone Systems was sold in 2008 to Eli Lilly and Co ( NYSE:LLY ) for $6.5bn, though not before the founder had been arrested for insider trading in the case that also roped in Martha Stewart.
